Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases

被引:5
|
作者
Sabater, Sebastia [1 ]
Mur, Encarna [2 ]
Mueller, Katrin [2 ]
Arenas, Meritxell [2 ]
机构
[1] Complejo Hosp Univ, Dept Radiat Oncol, ES-02006 Albacete, Spain
[2] St Joan Univ Hosp, Dept Radiat Oncol, Reus, Tarragona, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2012年 / 14卷 / 01期
关键词
ADL; IADL; Neurocognitive evaluation; Performance status; Brain metastases; RECURSIVE PARTITIONING ANALYSIS; MINI-MENTAL-STATE; QUALITY-OF-LIFE; RADIATION-THERAPY; PROGNOSTIC-FACTORS; COGNITIVE IMPAIRMENT; MOTEXAFIN GADOLINIUM; CEREBRAL METASTASES; RANDOMIZED-TRIAL; CANCER-PATIENTS;
D O I
10.1007/s12094-012-0760-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Brain radiotherapy is the main treatment for patients with brain metastases but its goal is just symptom control. Our aim was to study if different performance tools, used in geriatric practice, could improve patient selection for decision-making in the palliative brain radiotherapy setting. Data from 61 consecutive patients were analysed. In addition to Karnofsky Performance Status (KPS) their physical activity was assessed by means of the activity of daily living (ADL) and instrumental ADL (IADL) scales. A neurocognitive evaluation was performed with the Pfeiffer Short Portable Mental Status Questionnaire (SPMSQ) and with the Mini-Mental Status Exam (MMSE). Radiotherapy compliance and short survival were the endpoints of the study. High rates of cognitive impairment were found by both neurocognitive tools (Pfeiffer: 19.7% of patients; MMSE: 30%). Dependence was also highly prevalent, either measured by the ADL (50.8%) or by the IADL (43.3%). Nearly one third (27.9%) of patients died soon after radiotherapy evaluation. Longer survival was related to female, younger than 60 years, breast cancer primary tumour, steroid response, RPA class, and higher performance and neurocognitive score tools. A premature death was associated with neurocognitive tools, IADL and longer interval from brain metastatic diagnosis to radiotherapy. Twenty-three percent of patients were not able to finish the WBRT course due to clinical deterioration. The only variable related to compliance was a low MMSE score. Results suggest that the geriatric tools analysed could offer information on brain palliative radiotherapy complementary to that offered by the more usual tools. It will be interesting to study if our data could be extrapolated to the general palliative oncological field.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [1] Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases
    Sebastià Sabater
    Encarna Mur
    Katrin Müller
    Meritxell Arenas
    [J]. Clinical and Translational Oncology, 2012, 14 : 43 - 49
  • [2] Survival in patients with brain metastases treated with whole-brain radiotherapy
    Avila, Jorge
    [J]. REVISTA COLOMBIANA DE CANCEROLOGIA, 2018, 22 (03): : 99 - 104
  • [3] Predicting prognosis of short survival time after palliative whole-brain radiotherapy
    Miyazawa, Kazunari
    Shikama, Naoto
    Okazaki, Shohei
    Koyama, Tadaaki
    Takahashi, Takao
    Kato, Shingo
    [J]. JOURNAL OF RADIATION RESEARCH, 2018, 59 (01) : 43 - 49
  • [4] A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases
    Rades, Dirk
    Dunst, Juergen
    Schild, Steven E.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (05) : 251 - 255
  • [5] A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases
    Rades, D.
    Dunst, J.
    Schild, S. E.
    [J]. ONKOLOGIE, 2008, 31 : 168 - 168
  • [6] A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy (WBRT) for brain metastases
    Bohlen, G.
    Dunst, J.
    Schild, S.
    Rades, D.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 61 - 61
  • [7] Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy
    Doyle, Megan
    Bradley, Nicole Marie Eve
    Li, Kathy
    Sinclair, Emily
    Lam, Kelvin
    Chan, Grace
    Chow, Edward
    Barnes, Elizabeth A.
    Danjoux, Cyril
    Tsao, May N.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2007, 10 (02) : 367 - 374
  • [8] Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases
    Dziggel, L.
    Segedin, B.
    Podvrsnik, N. H.
    Oblak, I.
    Schild, S. E.
    Rades, D.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (05) : 364 - 366
  • [9] A New Score Predicting Survival Prognosis After Whole-Brain Radiotherapy Alone for Brain Metastases in Elderly Patients
    Evers, Jasmin N.
    Schild, Steven E.
    Segedin, Barbara
    Nagy, Viorica
    Mai Trong Khoa
    Ngo Thuy Trang
    Rades, Dirk
    [J]. ANTICANCER RESEARCH, 2014, 34 (05) : 2455 - 2458
  • [10] Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
    Brown, Paul D.
    Ahluwalia, Manmeet S.
    Khan, Osaama H.
    Asher, Anthony L.
    Wefel, Jeffrey S.
    Gondi, Vinai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 483 - +